25 - 27 November – Cologne, Germany

Axiogenesis Application Workshop
Great Assays For Neurons & Cardiomyocytes

Meet the Axiogenesis team and collaboration partners

Upcoming Application Workshop - Detailed Agenda now available.

Axiogenesis' Application Workshop "Great Assays on hiPSC-Derived Neurons and Cardiomyocytes" is taking place this week, Nov 25 to 27, 2015. We are excited to share our finalized Agenda, including interesting talks, live demonstrations of iPSC-based applications for toxicology, safety, and phenotypic screening, as well as various opportunities for networking with colleagues.

Click here for download


Axiogenesis Sublicenses GE Healthcare iPSC Patents

Axiogenesis AG has sublicensed patents from GE Healthcare to commercialize technologies based on human induced pluripotent stem cells (iPSCs). This solidifies the ability for Axiogenesis and its customers to apply Axiogenesis cell types in the development of cellular assays and stem cell-derived disease models for use in drug discovery and toxicity screening. For the complete press release, click here.

New Axiogenesis Web Site Launched

For the last couple of months, we worked behind the scenes on our new website. Today, we are proud to present to you our new face and welcome you to the Axiogenesis website! The new design enables us to present our growing portfolio and new products clearly arranged. 

Continue Reading


Nattermannallee 1, Bldg S20
50829 Cologne
Germany – (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)


Orders: order@axiogenesis.com
Support: support@axiogenesis.com
Other: office@axiogenesis.com


Twitter:   |   LinkedIn:   |   Newsletter: Subscribe Axiogenesis Newsletter


Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10